{"id":"W3204395813","doi":"10.1093/eurheartj/ehab674","title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":595,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Institutes of Health; Incyte; National Cancer Institute; Brigham and Women's Hospital; British Heart Foundation; Takeda Oncology; Austrian Science Fund; Amgen; Ariad Pharmaceuticals; Daiichi-Sankyo; Teva Pharmaceutical Industries; Acorda Therapeutics; Children's Discovery Institute; National Heart, Lung, and Blood Institute; Vifor Pharma; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Intensive care medicine; Clinical trial; Cancer; Clinical Practice; Heart failure; Internal medicine; Oncology; Family medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06563375,0.001652533,0.003029515,0.00539489,0.002185385,0.004880086,0.006712849,0.007873298,0.001540401],"category_scores_gemma":[0.05318023,0.0008425525,0.005228425,0.003360261,0.003861109,0.003742872,0.006780873,0.01700358,0.001798921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004736303,"about_ca_system_score_gemma":0.03065928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005811556,"about_ca_topic_score_gemma":0.008194163,"domain_scores_codex":[0.9719725,0.008865125,0.009239904,0.001004935,0.007719106,0.00119835],"domain_scores_gemma":[0.920623,0.03342089,0.007000037,0.002390116,0.03227342,0.004292489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002056064,0.0002600629,0.003893534,0.01060013,0.0003792162,0.000646056,0.001660721,0.003050636,0.001987059,0.03261206,0.4240297,0.5206752],"study_design_scores_gemma":[0.0001095541,0.0002276853,0.004451993,0.03055171,0.0004851701,0.00168109,0.001152153,0.001334065,0.001517418,0.02232186,0.9360154,0.0001519282],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.005052633,0.358662,0.06697857,0.4938754,0.03577925,0.002079399,0.002032713,0.0006591827,0.03488094],"genre_scores_gemma":[0.05073738,0.4449528,0.2517347,0.1972735,0.02575777,0.005110797,0.008742745,0.0005629929,0.01512727],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.06563375,"threshold_uncertainty_score":0.3471086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05349346076954907,"score_gpt":0.3487774273703979,"score_spread":0.2952839666008488,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}